Friday, 27 May 2022
  
Login

Australia's most trusted
source of pharma news

Friday, 27 May 2022
News

Omicron rewrites pandemic end

Posted 17 December 2021 PM

Like Delta before it, the Omicron variant is rewriting the timetable of the world getting to a post-pandemic normality, according to experts.

While preliminary data from small sample sizes suggests the Omicron variant could produce a less severe disease than Delta, its ability to evade the immune response combined with increased infectiousness means the disease burden could be greater than seen with previous variants.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (9)

Sales & Customer Relations (38)

Access & Reimbursement (4)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (5)

Devices (2)

Other (28)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.